Mikel Musatadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mikel Musatadi has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Olatz Zuloaga
Department of Analytical Chemistry, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Basque Country, Spain; Research Centre for Experimental Marine Biology and Biotechnology (PIE), University of the Basque Country (UPV/EHU), Plentzia, Basque Country, Spain
7 shared publications Maitane Olivares
Department of Analytical Chemistry
6 shared publicationsOlatz Zuloaga
Department of Analytical Chemistry, University of the Basque Country (UPV/EHU), Leioa, Basque Country, 48940, Spain; Plentzia Marine Station (PiE-UPV/EHU), Plentzia, Basque Country, 48620, Spain
6 shared publicationsAilette Prieto
Department of Analytical Chemistry, University of the Basque Country (UPV/EHU), 48940, Leioa, Basque Country, Spain; Research Centre for Experimental Marine Biology and Biotechnology, University of the Basque Country (UPV/EHU), 48620, Plentzia, Basque Country, Spain
5 shared publications- Ailette Prieto
Department of Analytical Chemistry, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Basque Country, Spain; Research Centre for Experimental Marine Biology and Biotechnology (PIE), University of the Basque Country (UPV/EHU), Plentzia, Basque Country, Spain
5 shared publications - Belén González-Gaya
Plentzia Marine Station (PiE), University of Basque Country (UPV/EHU), Areatza Hiribidea, 47, Bizkaia, Plentzia, Basque Country, 48620, Spain; Department of Analytical Chemistry, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Basque Country, 48940, Spain; IKERBASQUE, Basque Foundation for Science, Plaza Euskadi 5, Bilbao, 48009, Spain
5 shared publications
Latest Publications
- 18 September 2026
- Published by Elsevier
Contributors
- 18 September 2026
- Published by Elsevier
- p. 229-274
Gas chromatography for environmental analysis
- Open Access
- 26 June 2026
- Published by Elsevier in International Journal of Hygiene and Environmental Health
- Vol. 276, 114855
Advancing PFAS biomonitoring with a validated high-throughput suspect screening workflow in a longitudinal birth cohort
- 26 June 2026
- Published by Elsevier in International Journal of Hygiene and Environmental Health
- Vol. 276, 114855
Open AccessAdvancing PFAS biomonitoring with a validated high-throughput suspect screening workflow in a longitudinal birth cohort
- Open Access
- 7 November 2025
- Published by Elsevier in Environmental Pollution
- Vol. 388, 127359
Extending the chemical space in human urine by target and suspect screening of persistent and mobile organic compounds
- 7 November 2025
- Published by Elsevier in Environmental Pollution
- Vol. 388, 127359
Open AccessExtending the chemical space in human urine by target and suspect screening of persistent and mobile organic compounds
- 29 April 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (18) , 9683-9690
Electromembrane Extraction in Suspect Screening of Polar Organic Xenobiotics and their Metabolites in Human Urine: A New Approach to Enhance Compound Annotation?
Suspect and nontarget screening (SNTS) methodologies using human urine are invaluable strategies for understanding the human exposome. However, very polar organic compounds are often overlooked in those methods due to challenges in sample preparation and chromatographic analysis. Although "dilute-and-shoot" (DS) followed by mixed-mode liquid chromatography-high-resolution mass spectrometry (MMLC-HRMS) might be deemed suitable, complementary strategies are needed to enhance SNTS and expand compound identification. In this context, the potential of nonsupported microelectromembrane extraction (μ-EME) is thoroughly studied as a supplement to DS-MMLC-HRMS. It was demonstrated that μ-EME-MMLC-HRMS enables the refinement of suspect screening results from a 24 h pooled human urine sample. The selective extraction capability of μ-EME for charged analytes, compared to DS, allowed the identification of 24 false positives and 4 false negatives. The confidence level of 6 suspects was also enhanced through μ-EME interpretation. Moreover, nine suspects were identified exclusively in μ-EME experiments due to the urine cleanup provided by that technique. Notably, suspects containing carboxylic acid groups (phase II metabolites) and amines were particularly well-annotated by μ-EME employing selective extraction conditions for acids and bases, respectively. Thus, μ-EME proves to be a confirmatory dimension in MMLC-based SNTS approaches.
- 29 April 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (18) , 9683-9690
Electromembrane Extraction in Suspect Screening of Polar Organic Xenobiotics and their Metabolites in Human Urine: A New Approach to Enhance Compound Annotation?
Suspect and nontarget screening (SNTS) methodologies using human urine are invaluable strategies for understanding the human exposome. However, very polar organic compounds are often overlooked in those methods due to challenges in sample preparation and chromatographic analysis. Although "dilute-and-shoot" (DS) followed by mixed-mode liquid chromatography-high-resolution mass spectrometry (MMLC-HRMS) might be deemed suitable, complementary strategies are needed to enhance SNTS and expand compound identification. In this context, the potential of nonsupported microelectromembrane extraction (μ-EME) is thoroughly studied as a supplement to DS-MMLC-HRMS. It was demonstrated that μ-EME-MMLC-HRMS enables the refinement of suspect screening results from a 24 h pooled human urine sample. The selective extraction capability of μ-EME for charged analytes, compared to DS, allowed the identification of 24 false positives and 4 false negatives. The confidence level of 6 suspects was also enhanced through μ-EME interpretation. Moreover, nine suspects were identified exclusively in μ-EME experiments due to the urine cleanup provided by that technique. Notably, suspects containing carboxylic acid groups (phase II metabolites) and amines were particularly well-annotated by μ-EME employing selective extraction conditions for acids and bases, respectively. Thus, μ-EME proves to be a confirmatory dimension in MMLC-based SNTS approaches.
- 12 September 2024
- Published by American Chemical Society (ACS) in Environmental Science & Technology
In Vitro Metabolism of Quaternary Ammonium Compounds and Confirmation in Human Urine by Liquid Chromatography Ion-Mobility High-Resolution Mass Spectrometry
Quaternary ammonium compounds (QACs) are high-production chemicals used as cleaning and disinfecting agents. Due to their ubiquitous presence in the environment and several toxic effects described, human exposure to these chemicals gained increasing attention in recent years. However, very limited data on the biotransformation of QACs is available, hampering exposure assessment. In this study, three QACs (dimethyl dodecyl ammonium, C10-DDAC; benzyldimethyl dodecylammonium, C12-BAC; cetyltrimethylammonium, C16-ATMAC) commonly detected in indoor microenvironments were incubated with human liver microsomes and cytosol (HLM/HLC) simulating Phase I and II metabolism. Thirty-one Phase I metabolites were annotated originating from 19 biotransformation reactions. Four metabolites of C10-DDAC were described for the first time. A detailed assessment of experimental fragmentation spectra allowed to characterize potential oxidation sites. For each annotated metabolite, drift-tube ion-mobility derived collision cross section (DTCCSN2) values were reported, serving as an additional identification parameter and allowing the characterization of changes in DTCCSN2 values following metabolism. Lastly, eight metabolites, including four metabolites of both C12-BAC and C10-DDAC, were confirmed in human urine samples showing high oxidation states through introduction of up to four oxygen atoms. This is the first report of higher oxidized C10-DDAC metabolites in human urine facilitating future biomonitoring studies on QACs.
- 12 September 2024
- Published by American Chemical Society (ACS) in Environmental Science & Technology
In Vitro Metabolism of Quaternary Ammonium Compounds and Confirmation in Human Urine by Liquid Chromatography Ion-Mobility High-Resolution Mass Spectrometry
Quaternary ammonium compounds (QACs) are high-production chemicals used as cleaning and disinfecting agents. Due to their ubiquitous presence in the environment and several toxic effects described, human exposure to these chemicals gained increasing attention in recent years. However, very limited data on the biotransformation of QACs is available, hampering exposure assessment. In this study, three QACs (dimethyl dodecyl ammonium, C10-DDAC; benzyldimethyl dodecylammonium, C12-BAC; cetyltrimethylammonium, C16-ATMAC) commonly detected in indoor microenvironments were incubated with human liver microsomes and cytosol (HLM/HLC) simulating Phase I and II metabolism. Thirty-one Phase I metabolites were annotated originating from 19 biotransformation reactions. Four metabolites of C10-DDAC were described for the first time. A detailed assessment of experimental fragmentation spectra allowed to characterize potential oxidation sites. For each annotated metabolite, drift-tube ion-mobility derived collision cross section (DTCCSN2) values were reported, serving as an additional identification parameter and allowing the characterization of changes in DTCCSN2 values following metabolism. Lastly, eight metabolites, including four metabolites of both C12-BAC and C10-DDAC, were confirmed in human urine samples showing high oxidation states through introduction of up to four oxygen atoms. This is the first report of higher oxidized C10-DDAC metabolites in human urine facilitating future biomonitoring studies on QACs.
- Open Access
- 13 January 2024
- Published by Elsevier in Chemosphere
- Vol. 351, 141221
Development and evaluation of a comprehensive workflow for suspect screening of exposome-related xenobiotics and phase II metabolites in diverse human biofluids
- 13 January 2024
- Published by Elsevier in Chemosphere
- Vol. 351, 141221
Open AccessDevelopment and evaluation of a comprehensive workflow for suspect screening of exposome-related xenobiotics and phase II metabolites in diverse human biofluids